Sickle cell patients are missing out on an effective treatment despite widespread US hospital access to the technology, new research has found.
That treatment is called a red blood cell exchange, a procedure that discards a patient’s damaged red blood cells while simultaneously mixing the patient’s remaining plasma, platelets and white blood cells with red blood cells from a donor before returning them to the body.
